MAIA Biotechnology (MAIA) Times Interest Earned (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Times Interest Earned of -$21.12 for Q1 2026, up 8.04% year-over-year from -$19.55 in Q1 2025, and down 11096.92% quarter-over-quarter from -$0.19 in Q4 2025.
MAIA Biotechnology (MAIA) Times Interest Earned (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Times Interest Earned for 6 consecutive years, with -$21.12 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 8.04% year-over-year to -$21.12; the TTM figure through Mar 2026 stood at -$78.4 (changed 0.45% YoY), while the FY2025 annual figure was -$1.06, up 5.01% from the prior year.
- Times Interest Earned declined to -$21.12 in Q1 2026 per MAIA's latest filing, from -$0.19 in the prior quarter.
- Across five years, Times Interest Earned topped out at $178735.9 in Q4 2024 and bottomed at -$815.04 in Q4 2022.
- Historically, Times Interest Earned has averaged $11854.9 across 5 years, with a median of -$1.53 in 2024.
- Annual changes were most pronounced in 2022 — Times Interest Earned surged 87.94% — and 2025, when it slumped 6138.58%.
- MAIA Biotechnology's Times Interest Earned stood at -$815.04 in 2022, then soared by 99.71% to -$2.33 in 2023, then soared by 7682934.07% to $178735.9 in 2024, then slumped by 100.0% to -$0.19 in 2025, then slumped by 11096.92% to -$21.12 in 2026.
- Business Quant data shows MAIA's Times Interest Earned at -$21.12 in Q1 2026, -$0.19 in Q4 2025, and -$37.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.21 |
| Mar 31, 2026 | -21.12 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -37.11 |
| Jun 30, 2025 | -8.23 |
| Mar 31, 2025 | -22.97 |
| Dec 31, 2024 | 178,735.86 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -1.53 |
| Sep 30, 2023 | -2.33 |
| Jun 30, 2023 | -2.21 |
| Mar 31, 2023 | -0.47 |
| Dec 31, 2022 | -815.04 |
| Sep 30, 2022 | -0.60 |
| Jun 30, 2022 | -0.20 |
| Sep 30, 2021 | -4.95 |